查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1363332

CRRT（连续肾臟替代疗法）市场规模、份额、趋势分析报告：按产品、按方式、按地区、细分趋势，2023-2030

Continuous Renal Replacement Therapy Market Size, Share & Trends Analysis Report By Product (System, Consumables), By Modality, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10个工作天内

价格

CRRT（连续性肾臟替代疗法）市场成长与趋势：

Grand View Research 的最新报告显示，到 2030 年，全球 CRRT（连续性肾臟替代治疗）市场规模预计将达到 26.038 亿美元。

预计2023年至2030年该市场将以8.6%的年复合成长率扩张。市场成长的主要促进因素是充血性心臟衰竭和急性肾衰竭的患病不断增加。由于急性患病盛行率增加，预计 COVID-19 将对市场产生积极影响。据世界卫生组织称，急性肾损伤是一种可能危及生命的疾病，其中肾臟停止功能，尿毒症和液体毒素在体内积聚，是 COVID-19 的众多副作用之一。因此，随着 COVID-19 疫情的蔓延，对 CRRT 的需求可能会持续上升。

预计技术进步将成为预测期内市场成长的关键驱动力。例如，2020年8月，全球急诊护理领域的领导者百特国际公司（Baxter International）其用于体外循环局部柠檬酸盐抗凝的含有Regiocit柠檬酸盐的替换溶液获得美国食品药物管理局（ FDA）的批准，并宣布已收到紧急通知使用授权 (EUA)。根据 EUA 的规定，Regiosit 专门用于在 COVID-19核准流行期间接受 CRRT（连续肾臟替代治疗）且需要局部柠檬酸盐抗凝血的成年患者的替代液。

CRRT（持续性肾臟替代疗法）市场报告亮点

  • 以按产品来看，消耗品板块的销售份额最大，2022年将达到60.6%。与其他细分市场相比，消耗品市场是最大的，因为这些产品价格低廉，但可以重复购买和使用。
  • 按方式分，连续静脉血液滤过（CVVH）领域在 2022 年占据最大的销售份额，为 31.6%。重症监护病房急性肾损伤患者中常见的液体超负荷情况预计会增加，从而推动 CVVH 市场的成长。
  • CRRT（持续性肾臟替代治疗）市场是亚太地区成长最快的市场，成长率为9.8%。该地区的成长受到多种要素的推动，包括技术进步、医疗基础设施的发展以及庞大的患者基础。

目录

第1章调查方法与范围

第2章执行摘要

第3章CRRT（持续性肾臟替代治疗）市场变数、趋势与范围

  • 市场体系预测
    • 母市场预测
    • 相关/附随市场预测
  • 普及和成长预测图
  • 市场动态
    • 市场促进因素分析
    • 市场抑制因素分析
  • CRRT（持续性肾臟替代疗法）市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第4章CRRT（持续性肾臟替代疗法）市场：按产品估计和趋势分析

  • CRRT（连续肾臟替代治疗）市场：重点
  • CRRT（持续性肾臟替代疗法）市场：2022 年和 2030 年趋势和市场占有率分析
  • 系统
  • 消耗品

第5章CRRT（持续性肾臟替代治疗）市场：依模式估计与趋势分析

  • CRRT（连续肾臟替代治疗）市场：重点
  • CRRT（持续性肾臟替代疗法）市场：2022 年和 2030 年趋势和市场占有率分析
  • 慢速超过滤(SCUF)
  • 连续性静脉静脉血液滤过（CVVH）
  • 连续性静脉-静脉血液透析机（CVVHD）
  • 连续性静脉-静脉血液透析机（CVVHDF）

第6章CRRT（持续性肾臟替代治疗）市场：区域估计与趋势分析

  • 区域展望
  • CRRT（连续肾臟替代治疗）市场（按地区）：重点
  • 北美洲
    • 2018-2030 年市场估计与预测
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿拉伯聯合大公国
    • 科威特

第7章竞争形势

  • 主要参与企业的最新发展和影响分析
  • 市场参与企业分类
    • B. BRAUN MELSUNGEN AG
    • BAXTER INTERNATIONAL, INC.
    • FRESENIUS MEDICAL CARE AG & CO. KGAA
    • ASAHI KASEI CORPORATION
    • NIPRO CORPORATION
    • TORAY MEDICAL CO., LTD.
    • NXSTAGE MEDICAL, INC
    • MEDTRONIC PLC
Product Code: GVR-1-68038-607-3

Continuous Renal Replacement Therapy Market Growth & Trends:

The global continuous renal replacement therapy market size is anticipated to reach USD 2,603.8 million by 2030, according to a new report by Grand View Research, Inc.. The market is expected to expand at a CAGR of 8.6% from 2023 to 2030. The primary driving factors for market growth are increasing prevalence of congestive heart failure and acute renal failure. The COVID-19 is expected to have a positive impact on market due to increasing prevalence of acute kidney injury. According to a WHO, acute kidney injury, a potentially life-threatening condition in which the kidneys cease working and uremic and fluid toxins build up in the body, is one of the many COVID-19 side effects. As a result, as the COVID-19 outbreak expands, demand for CRRT will continue to climb.

Over the forecast period, technological advancements are expected to be a crucial driver in the growth of the market. For example, in August 2020, Baxter International Inc., a global leader in acute care, announced that Regiocit, the company's replacement solution containing citrate for extracorporeal circuit regional citrate anticoagulation, has acquired an Emergency Use Authorization (EUA) from the U.S Food and Drug Administration (FDA). Regiocit is exclusively approved for use as a replacement solution in adult patients receiving Continuous Renal Replacement Therapy (CRRT) and who require regional citrate anticoagulation during the COVID-19 pandemic, according to the EUA.

Continuous Renal Replacement Therapy Market Report Highlights:

  • By product, the consumables segment held the largest revenue share of 60.6% in 2022. Although these products are low-priced, it is used repeatedly purchased; hence the market for consumables is the largest as compared to other segments
  • Based on the modality, the Continuous Veno-venous Hemofiltration (CVVH) segment held the largest revenue share of 31.6% in 2022. Fluid overload situations, which are common in acute kidney injury patients in critical care units, are expected to increase, boosting the CVVH market's growth
  • Asia Pacific was the fastest growing market for continuous renal replacement therapy with a growth rate of 9.8%. Various factors are responsible for the region growth such as technological advancement, growing healthcare infrastructure development as well as and presence of such a huge patient base in this region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Modality
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Modality outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Continuous Renal Replacement Therapy Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Continuous Renal Replacement Therapy Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Continuous Renal Replacement Therapy Market: Product Estimates & Trend Analysis

  • 4.1. Continuous Renal Replacement Therapy Market: Key Takeaways
  • 4.2. Continuous Renal Replacement Therapy Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. System
    • 4.3.1. System market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Consumables
    • 4.4.1. Consumables market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Continuous Renal Replacement Therapy Market: Modality Class Estimates & Trend Analysis

  • 5.1. Continuous Renal Replacement Therapy Market: Key Takeaways
  • 5.2. Continuous Renal Replacement Therapy Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Slow Continuous Ultra-Filtration (SCUF)
    • 5.3.1. Slow continuous ultra-filtration market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Continuous Venovenous Hemofiltration (CVVH)
    • 5.4.1. Continuous venovenous hemofiltration (CVVH) market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Continuous Venovenous Hemodialysis (CVVHD)
    • 5.5.1. Continuous venovenous hemodialysis (CVVHD) market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Continuous Venovenous Hemodiafiltration (CVVHDF)
    • 5.6.1. Continuous venovenous hemodiafiltration (CVVHDF) market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Continuous Renal Replacement Therapy Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Continuous Renal Replacement Therapy Market by Region: Key Takeaways
  • 6.3. North America
    • 6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.4. Europe
    • 6.4.1. U.K.
      • 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.3. France
      • 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.6. Sweden
      • 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.7. Norway
      • 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.2. China
      • 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.3. India
      • 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.5. Thailand
      • 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.6. South Korea
      • 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. Mexico
      • 6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7. MEA
    • 6.7.1. Saudi Arabia
      • 6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.2. South Africa
      • 6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Participants
  • 7.2. Market Participant Categorization
    • 7.2.1. B. BRAUN MELSUNGEN AG
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. BAXTER INTERNATIONAL, INC.
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. FRESENIUS MEDICAL CARE AG & CO. KGAA
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. ASAHI KASEI CORPORATION
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. NIPRO CORPORATION
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. TORAY MEDICAL CO., LTD.
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. NXSTAGE MEDICAL, INC
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. MEDTRONIC PLC
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 3 North America continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 4 North America continuous renal replacement therapy market, by region, 2018 - 2030 (USD Million)
  • Table 5 U.S. continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 6 U.S. continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 7 Canada continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 8 Canada continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 9 Europe continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 10 Europe continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 11 Europe continuous renal replacement therapy market, by region, 2018 - 2030 (USD Million)
  • Table 12 Germany continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 13 Germany continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 14 UK continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 15 UK continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 16 France continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 17 France continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 18 Italy continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 19 Italy continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 20 Spain continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 21 Spain continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 22 Sweden continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 23 Sweden continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 24 Norway continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 25 Norway continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 26 Denmark continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 27 Denmark continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific continuous renal replacement therapy market, by region, 2018 - 2030 (USD Million)
  • Table 31 Japan continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 32 Japan continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 33 China continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 34 China continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 35 India continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 36 India continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 37 Australia continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 38 Australia continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 39 Thailand continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 40 Thailand continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 41 South Korea continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 42 South Korea continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 43 Latin America continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 44 Latin America continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 45 Latin America continuous renal replacement therapy market, by region, 2018 - 2030 (USD Million)
  • Table 46 Brazil continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 47 Brazil continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 48 Mexico continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 49 Mexico continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 50 Argentina continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 51 Argentina continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 52 Middle East and Africa continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 53 Middle East and Africa continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 54 Middle East and Africa continuous renal replacement therapy market, by region, 2018 - 2030 (USD Million)
  • Table 55 South Africa continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 56 South Africa continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 59 UAE continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 60 UAE continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 61 Kuwait continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 62 Kuwait continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Continuous renal replacement therapy: market outlook
  • Fig. 9 Continuous renal replacement therapy competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Continuous renal replacement therapy market driver impact
  • Fig. 15 Continuous renal replacement therapy market restraint impact
  • Fig. 16 Continuous renal replacement therapy market strategic initiatives analysis
  • Fig. 17 Continuous renal replacement therapy market: Product movement analysis
  • Fig. 18 Continuous renal replacement therapy market: Product outlook and key takeaways
  • Fig. 19 System market estimates and forecasts, 2018 - 2030
  • Fig. 20 Consumables market estimates and forecasts, 2018 - 2030
  • Fig. 21 Continuous renal replacement therapy market: Modality class outlook movement analysis
  • Fig. 22 Continuous renal replacement therapy market: Modality class outlook and key takeaways
  • Fig. 23 Slow continuous ultra-filtration market (SCUF) estimates and forecasts, 2018 - 2030
  • Fig. 24 Continuous venovenous hemofiltration (CVVH) market estimates and forecasts, 2018 - 2030
  • Fig. 25 Continuous venovenous hemodialysis (CVVHD) market estimates and forecasts, 2018 - 2030
  • Fig. 26 Continuous venovenous hemodiafiltration (CVVHDF) market estimates and forecasts, 2018 - 2030
  • Fig. 27 Continuous renal replacement therapy market: Regional movement analysis
  • Fig. 28 Continuous renal replacement therapy market: Regional outlook and key takeaways
  • Fig. 29 North America market estimates and forecasts, 2018 - 2030
  • Fig. 30 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 31 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 32 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 33 UK market estimates and forecasts, 2018 - 2030
  • Fig. 34 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 35 France market estimates and forecasts, 2018 - 2030
  • Fig. 36 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 37 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 38 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 39 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 40 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 41 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 42 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 43 China market estimates and forecasts, 2018 - 2030
  • Fig. 44 India market estimates and forecasts, 2018 - 2030
  • Fig. 45 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 46 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 47 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 48 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 49 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 50 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 51 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 52 Middle East and Africa. market estimates and forecasts, 2018 - 2030
  • Fig. 53 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 54 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 55 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 56 Kuwait market estimates and forecasts, 2018 - 2030